SunTrust Reiterates R Rating for Hologic (HOLX)
Hologic (NASDAQ:HOLX)‘s stock had its “r” rating reaffirmed by equities researchers at SunTrust in a research report issued on Thursday. They currently have a $18.00 target price on the stock, up from their previous target price of $15.00. SunTrust’s price target points to a potential downside of 30.96% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at ISI Group raised their price target on shares of Hologic from $27.00 to $29.00 in a research note on Wednesday, July 9th. Separately, analysts at BTIG Research downgraded shares of Hologic from a “buy” rating to a “neutral” rating in a research note on Monday, July 7th. Finally, analysts at Standpoint Research downgraded shares of Hologic from a “buy” rating to a “hold” rating in a research note on Wednesday, July 2nd. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $24.50.
Shares of Hologic (NASDAQ:HOLX) traded up 0.42% during mid-day trading on Thursday, hitting $26.07. The stock had a trading volume of 3,472,444 shares. Hologic has a 52-week low of $19.25 and a 52-week high of $26.35. The stock’s 50-day moving average is $25.38 and its 200-day moving average is $22.97. The company’s market cap is $7.204 billion.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.03. The company had revenue of $632.60 million for the quarter, compared to the consensus estimate of $621.89 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The company’s revenue for the quarter was up 1.0% on a year-over-year basis. On average, analysts predict that Hologic will post $1.40 earnings per share for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.